ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
프로게스테론 시장 규모는 최근 급성장하고 있습니다. 2025년 17억 9,000만 달러에서 2026년에는 20억 6,000만 달러에 이르고, CAGR 14.8%의 성장이 전망되고 있습니다. 지난 수년간의 성장에는 천연 프로게스테론의 구하기 어려움, 브랜드 제제에 대한 의존도, 갱년기 치료에 대한 인식 개선, 기능성 자궁출혈 발생률 증가, 기존 경구피임약의 보급 등이 요인으로 작용한 것으로 추정됩니다.
프로게스테론 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 35억 4,000만 달러에 이르고, CAGR은 14.5%를 나타낼 전망입니다. 예측 기간 동안의 성장 요인으로는 합성 프로게스틴 및 첨단 전달 시스템 개발, 맞춤형 호르몬 요법에 대한 수요 증가, 불임 치료 및 피임 클리닉의 확대, 자궁내막암 치료 연구의 진전, 저침습적 투여 경로의 채택 등을 들 수 있습니다. 예측 기간 동안 주요 동향으로는 천연 프로게스테론 제제에 대한 수요 증가, 호르몬 대체 요법(HRT) 사용 확대, 주사제 및 경피제 사용 증가, 피임 및 불임 치료 확대, 개인 맞춤형 의료 및 자궁 내막 건강에 대한 관심 증가 등이 있습니다.
호르몬 장애의 유병률 증가는 향후 몇 년 동안 프로게스테론 시장 성장을 견인할 것으로 예측됩니다. 호르몬 장애는 대사, 성장, 생식, 기분 조절 등 중요한 기능을 담당하는 호르몬의 생산과 조절을 담당하는 내분비계의 불균형이나 기능 장애로 인해 발생하는 질환입니다. 호르몬 장애 증가는 건강에 해로운 식습관, 지속적인 스트레스, 운동 부족, 환경독소 노출 등 현대인의 생활습관 요인에 기인하는 바가 큽니다. 프로게스테론은 호르몬 균형 회복, 생리주기 조절, 에스트로겐 우위에 따른 증상 완화를 통해 호르몬 장애 관리에 중요한 역할을 합니다. 또한, 에스트로겐과 코티솔과 같은 다른 호르몬의 작용을 돕고 내분비계의 전반적인 안정에 기여하여 다낭성난소증후군(PCOS), 월경전증후군(PMS) 등의 질환을 관리하는데도 도움이 됩니다. 예를 들어, 스위스에 본부를 둔 정부 간 기구인 세계보건기구(WHO)는 2025년 1월 다낭성 난소 증후군을 가임기 여성의 주요 공중보건 문제이자 가장 흔한 호르몬 장애 중 하나로 꼽았으며, 연간 약 6-13%의 여성이 이 질환을 앓고 있다고 보고했습니다. 이러한 이유로 호르몬 장애 증가 추세는 프로게스테론 시장의 성장을 가속하고 있습니다.
프로게스테론 시장에서 사업을 전개하고 있는 주요 기업들은 환자의 복약 순응도 향상과 약물 흡수율 개선을 목표로 소프트 질 내 캡슐과 같은 혁신적인 제제 개발에 주력하고 있습니다. 소프트 질 내 캡슐은 부드러운 젤 유형의 질 내 투여용 삽입물로, 약물을 표적 부위에 직접 전달하여 호르몬 균형 유지, 질병 치료, 질 건강 유지에 도움을 줍니다. 예를 들어, 2024년 4월 영국에 본사를 둔 제약사 베신스 헬스케어(UK) 리미티드(Vessins Healthcare(UK) Limited)는 반복적인 유산 경험이 있는 임신 초기 출혈을 경험한 여성의 유산 예방을 목적으로 한 '프로메트리움 400mg 소프트 질 내 캡슐'을 출시했습니다. 이 신약은 영국에서 최초로 허가된 동종 제품으로서, 작용 부위에서 프로게스테론 흡수를 촉진하는 표적 지향적 비침습적 투여 방식을 통해 치료 효과와 환자의 복약 순응도를 향상시킬 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Progesterone is a steroid hormone that plays a key role in the menstrual cycle, pregnancy, and embryonic development in humans and other species. It prepares the endometrium, or uterine lining, for the possible implantation of a fertilized egg, supports early pregnancy, and suppresses further ovulation during pregnancy. Progesterone is also widely used in hormone replacement therapy and in birth control pills, where it is present in synthetic forms known as progestins.
The main product types of progesterone include natural progesterone and synthetic progesterone. Natural progesterone, often described as bioidentical progesterone, is a hormone sourced from plants such as soybeans or wild yams. These products are available in both branded and generic versions and can be administered through several routes, including injectable, oral, transdermal, and other methods. Progesterone is used for a variety of applications, including menopause management, contraception, dysfunctional uterine bleeding, hyperplastic precursor lesions, endometrial cancer, and other indications. The primary end users include hospitals, clinics, research institutions, and other healthcare settings.
Tariffs have influenced the progesterone market by increasing costs of imported raw materials and pharmaceutical intermediates, particularly affecting natural progesterone extraction and synthetic progestin manufacturing. Segments such as injectable formulations and transdermal products are most impacted, with regions like Europe and Asia-Pacific facing notable import duties. This has led to higher production costs and adjustments in supply chains. On the positive side, tariffs encourage local production, innovation in cost-efficient formulations, and development of domestic hormone therapy manufacturing capacities.
The progesterone market research report is one of a series of new reports from The Business Research Company that provides progesterone market statistics, including progesterone industry global market size, regional shares, competitors with a progesterone market share, detailed progesterone market segments, market trends and opportunities, and any further data you may need to thrive in the progesterone industry. This progesterone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The progesterone market size has grown rapidly in recent years. It will grow from $1.79 billion in 2025 to $2.06 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to limited availability of natural progesterone, reliance on branded formulations, growing awareness of menopausal therapies, increasing incidence of dysfunctional uterine bleeding, adoption of conventional oral contraceptives.
The progesterone market size is expected to see rapid growth in the next few years. It will grow to $3.54 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to development of synthetic progestins and advanced delivery systems, rising demand for personalized hormone therapy, growth in fertility and contraceptive clinics, increasing research in endometrial cancer treatment, adoption of minimally invasive administration routes. Major trends in the forecast period include rising demand for natural progesterone formulations, growth in hormone replacement therapy (hrt) usage, increasing adoption of injectable and transdermal routes, expansion of contraceptive and fertility treatments, focus on personalized medicine and endometrial health.
The rising prevalence of hormonal disorders is anticipated to drive the growth of the progesterone market in the coming years. Hormonal disorders are medical conditions that arise from imbalances or dysfunctions within the body's endocrine system, which is responsible for producing and regulating hormones that control essential functions such as metabolism, growth, reproduction, and mood. The growing occurrence of hormonal disorders is largely attributed to modern lifestyle factors, including unhealthy diets, persistent stress, physical inactivity, and exposure to environmental toxins. Progesterone plays a key role in managing hormonal disorders by helping restore hormonal balance, regulate menstrual cycles, and alleviate symptoms associated with estrogen dominance. It also supports the activity of other hormones, such as estrogen and cortisol, contributing to overall endocrine stability and helping manage conditions like polycystic ovary syndrome (PCOS) and premenstrual syndrome (PMS). For instance, in January 2025, according to the World Health Organization, a Switzerland-based intergovernmental organization, polycystic ovary syndrome was identified as a major public health concern and one of the most prevalent hormonal disorders among women of reproductive age, affecting an estimated 6-13% annually. Therefore, the increasing prevalence of hormonal disorders is fueling the growth of the progesterone market.
Major companies operating in the progesterone market are concentrating on the development of innovative formulations, such as soft vaginal capsules, to enhance patient adherence and improve drug absorption. Soft vaginal capsules are smooth, gel-based inserts intended for vaginal administration that deliver medication directly to the target area, supporting hormonal balance, treating conditions, and maintaining vaginal health. For example, in April 2024, Besins Healthcare (UK) Limited, a UK-based pharmaceutical manufacturing company, introduced Prometrium 400 mg soft vaginal capsules for the prevention of miscarriage in women experiencing early pregnancy bleeding with a history of recurrent miscarriage. This novel formulation is the first licensed product of its kind in the UK and is designed to improve treatment outcomes and patient compliance by providing a targeted, non-invasive delivery approach that enhances progesterone absorption at the site of action.
In October 2024, Audax Private Equity, a US-based private equity firm, acquired the clinical services business of Avantor, Inc. for an undisclosed amount. Through this acquisition, Audax aims to establish the business-now rebranded as Resonant Clinical Solutions-as an independent platform within the outsourced clinical trial services market, strengthening its service capabilities and leveraging established customer relationships. Avantor, Inc. is a US-based biotechnology company that specializes in supplying progesterone.
Major companies operating in the progesterone market are Pfizer Inc., Johnson & Johnson, Merck & Co Inc., Allergan plc, AbbVie Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd, Gedeon Richter Plc., Dr. Reddy's Laboratories Ltd., Cipla Limited, Cadila Pharmaceuticals Ltd., Aspen Pharmacare, BIOCON Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Beximco Pharmaceuticals Ltd., Besins healthcare (UK) limited., Sichuan Deebio Pharmaceutical Co. Ltd., Changzhou Siyao Pharmaceuticals Co. Ltd., Shanghai Shyndec Pharmaceutical Co. Ltd.
North America was the largest region in the progesterone market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the progesterone market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the progesterone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The progesterone market consists of sales of oral capsules, vaginal gels, creams, injections, and intrauterine devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Progesterone Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses progesterone market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for progesterone ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The progesterone market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Product Type: Natural Progesterone; Synthetic Progesterone
2) By Drug Type: Branded; Generic
3) By Route Of Administration: Injectable; Oral; Transdermal; Other Routes Of Administration
4) By Application: Menopause; Contraception; Dysfunctional Uterine Bleeding; Hyperplastic Precursor Lesions; Endometrial Cancer; Other Applications
5) By End-User: Hospitals; Clinics; Research Institutes; Other End-Users
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Rising Demand For Natural Progesterone Formulations
4.2.2 Growth In Hormone Replacement Therapy (Hrt) Usage
4.2.3 Increasing Adoption Of Injectable And Transdermal Routes
4.2.4 Expansion Of Contraceptive And Fertility Treatments
4.2.5 Focus On Personalized Medicine And Endometrial Health
5. Progesterone Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Clinics
5.3 Research Institutes
5.4 Fertility And Contraceptive Centers
5.5 Pharmaceutical Companies
6. Progesterone Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Progesterone Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Progesterone PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Progesterone Market Size, Comparisons And Growth Rate Analysis
7.3. Global Progesterone Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Progesterone Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Progesterone Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Progesterone Market Segmentation
9.1. Global Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Natural Progesterone, Synthetic Progesterone
9.2. Global Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Branded, Generic
9.3. Global Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Injectable, Oral, Transdermal, Other Routes Of Administration
9.4. Global Progesterone Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10. Progesterone Market Regional And Country Analysis
10.1. Global Progesterone Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Progesterone Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Progesterone Market
11.1. Asia-Pacific Progesterone Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Progesterone Market
12.1. China Progesterone Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Progesterone Market
13.1. India Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Progesterone Market
14.1. Japan Progesterone Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Progesterone Market
15.1. Australia Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Progesterone Market
16.1. Indonesia Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Progesterone Market
17.1. South Korea Progesterone Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Progesterone Market
18.1. Taiwan Progesterone Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Progesterone Market
19.1. South East Asia Progesterone Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Progesterone Market
20.1. Western Europe Progesterone Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Progesterone Market
21.1. UK Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Progesterone Market
22.1. Germany Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Progesterone Market
23.1. France Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Progesterone Market
24.1. Italy Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Progesterone Market
25.1. Spain Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Progesterone Market
26.1. Eastern Europe Progesterone Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Progesterone Market
27.1. Russia Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Progesterone Market
28.1. North America Progesterone Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Progesterone Market
29.1. USA Progesterone Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Progesterone Market
30.1. Canada Progesterone Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Progesterone Market
31.1. South America Progesterone Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Progesterone Market
32.1. Brazil Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Progesterone Market
33.1. Middle East Progesterone Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Progesterone Market
34.1. Africa Progesterone Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Progesterone Market, Segmentation By Product Type, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Progesterone Market Regulatory and Investment Landscape
36. Progesterone Market Competitive Landscape And Company Profiles
36.1. Progesterone Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Progesterone Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Progesterone Market Company Profiles
36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Allergan plc Overview, Products and Services, Strategy and Financial Analysis
36.3.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
37. Progesterone Market Other Major And Innovative Companies
